Astrocytes increase the functional expression of P-glycoprotein in an in vitro model of the blood-brain barrier

Pharmaceutical Research

Volumn 17, Issue 10, 2000, Pages 1198-1205

  Gaillard, P J ^a   Van Der Sandt, I C J ^a   Voorwinden, L H ^a   Vu, D ^a   Nielsen, J L ^a   De Boer, A G ^a   Breimer, D D ^a  

^a LEIDEN UNIVERSITY   (Netherlands)

Author keywords

Astrocytes; Blood brain barrier; Brain capillary endothelial cells; Multidrug resistance; P glycoprotein; Vinblastine exclusion assay

Indexed keywords

GLYCOPROTEIN P; VINBLASTINE;

ARTICLE; ASTROCYTE; BLOOD BRAIN BARRIER; BRAIN CAPILLARY; CONTROLLED STUDY; CYTOTOXICITY; DRUG ACCUMULATION; DRUG TRANSPORT; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSCYTOSIS;

EID: 0033638592     PISSN: 07248741     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1026406528530     Document Type: Article

References (28)

1. Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites
2. P-glycoprotein as the drug efflux pump in primary cultured bovine brain capillary endothelial cells
3. Inhibition of P-glycoprotein: Rapid assessment of its implication in blood-brain barrier integrity and drug transport to the brain by an in vitro model of the blood-brain barrier
4. Functional expression of P-glycoprotein in an immortalised cell line of rat brain endothelial cells, RBE 4
5. Astrocytes induce blood-brain barrier properties in endothelial cells
6. Brain microvascular and astrocyte localization of P-glycoprotein
7. Involvement of P-glycoprotein in an in vitro blood-brain barrier model
8. A general pattern for substrate recognition by P-glycoprotein
9. Specificity of doxorubicin versus thodamine-123 in assessing P-glycoprotein functionality in the LLC-PK1, LLC-PK1:MDR1 and Caco-2 cell lines
10. Role of the endothelial cytoskeleton in blood-brain-barrier permeability to protein
11. Molecular architecture of tight junctions
12. Functional expression of the P-glycoprotein mdr in primary cultures of bovine cerebral capillary endothelial cells
13. P-glycoprotein of blood brain barrier: Cross-reactivity of Mab C219 with a 190 kDa protein in bovine and rat isolated brain capillaries
14. Heterogeneity in P-glycoprotein (multidrug resistance) activity among murine peripheral T cells: Correlation with surface phenotype and effector function
15. Regulation of the movement of solutes across tight junctions
16. Modification of the blood-brain barrier permeability by vinorelbine: Effect of intracarotid infusion compared with intravenous infusion
17. Relationship of octanol/water partition coefficient and molecular weight to rat brain capillary permeability
18. P-glycoprotein in the blood-brain barrier of mice influences the brain penetration and pharmacological activity of many drugs
19. P-glycoprotein and pharmacokinetics
20. BBB transport and P-glycoprotein functionality using MDR1A (-/-) and wild-type mice. Total brain versus microdialysis concentration profiles of rhodamine- 123
21. Penetration of dexamethasone into brain glucocorticoid targets is enhanced in mdr1A P-glycoprotein knockout mice
22. Etoposide-induced blood-brain barrier disruption. Effect of drug compared with that of solvents
23. Localized changes in blood-brain barrier permeability following the administration of antineoplastic drugs
24. Phase I trial of etoposide with cyclosporine as a modulator of multidrug resistance
25. Phase I trial of doxorubicin with cyclosporine as a modulator of multidrug resistance
26. MDR expression in normal tissues. Pharmacologic implications for the clinical use of P-glycoprotein inhibitors
27. Multidrug resistance protein 1 protects the oropharyngeal mucosal layer and the testicular tubules against drug-induced damage
28. Role of tight junctions in establishing and maintaining cell polarity